Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

ClinicalTrials.gov ID: NCT03056690

Public ClinicalTrials.gov record NCT03056690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 11, 2026, 11:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study assessed analgesic efficacy of ASP0819 relative to placebo as well as the safety and tolerability. This study assessed treatment differences in physical function as well as the improvements in overall subject status (e.g., fibromyalgia symptoms and global functioning) of ASP0819 relative to placebo.

Study identification

NCT ID
NCT03056690
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
186 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2017 (Actual)
Primary completion
Feb 27, 2018 (Actual)
Completion
Feb 27, 2018 (Actual)
Last update posted
Oct 29, 2024

2017 – 2018

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Site US10025 - Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Site US10045 - TriWest Research Associates El Cajon California 92020 —
Site US10039 - Superior Research LLC Sacramento California 95831 —
Site US10003 - Artemis Inst For Clin Research San Diego California 92103 —
Site US10048 - Diablo Clinical Research Inc Walnut Creek California 94598 —
Site US10028 - Renstar Medical Research Ocala Florida 34471 —
Site US10024 - Compass Research LLC Orlando Florida 32806 —
Site US10012 - Palm Beach Research Center West Palm Beach Florida 33409 —
Site US10056 - Atlanta Ctr for Med Research Atlanta Georgia 30331 —
Site US10006 - Columbus Regional Research Ins Columbus Georgia 31904 —
Site US10038 - Heartland Research Associates Wichita Kansas 67205 —
Site US10055 - Central Kentucky Research Asc Lexington Kentucky 40509 —
Site US10027 - BTC of New Bedford LLC New Bedford Massachusetts 02740 —
Site US10018 - Altea Research Institute Las Vegas Nevada 89102 —
Site US10010 - Upstate Clinical Research Asc Williamsville New York 14221 —
Site US10032 - Peters Medical Research High Point North Carolina 27262 —
Site US10031 - Wake Research Associates Raleigh North Carolina 27612 —
Site US10019 - Lillestol Research LLC Fargo North Dakota 58103 —
Site US10037 - Dept of Psychiatry and Neuro University of Cincinnati Cincinnati Ohio 45219 —
Site US10059 - Hillcrest Clinical Oklahoma City Oklahoma 73119 —
Site US10043 - Oregon Ctr for Clinical Invest Portland Oregon 97214 —
Site US10023 - Oregon Ctr for Clinical Invest Salem Oregon 97301 —
Site US10013 - Bateman Horne Center Salt Lake City Utah 84102 —
Site US10005 - Charlottesville Med Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03056690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2024 · Synced Oct 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03056690 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →